Search Within

Geoffrey Yuyat Ku

  1. "2024"
Formats
  1. Meeting Abstract (10)
  2. Journal Article (5)
  3. Review (2)
  4. Book Section (1)
  5. Guidelines (1)
Groups
  1. Department of Medicine (19)
  2. Gastrointestinal Oncology Service (19)
  3. Hematologic Malignancies, Division of (19)
  4. Solid Tumor Oncology Division (19)
  5. Survivorship Research (8)
  6. Department of Pathology and Laboratory Medicine (7)

More Groups

People
  1. Laura Tang (6)
  2. Steven Maron (6)
  3. Yelena Janjigian (6)
  4. David Ilson (5)
  5. Daniel Coit (3)
  6. Daniela Molena (3)

More People

Years
  1. 2024 (19)
Publications
  1. Journal of Clinical Oncology (6)
  2. Annals of Oncology (4)
  3. Annals of Surgical Oncology (1)
  4. Cancer Consult: Expertise in Clinical Practice. 2nd ed (1)
  5. Current Opinion in Oncology (1)
  6. Gastric Cancer (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (6)
  2. Oxford University Press (5)
  3. Elsevier Inc. (2)
  4. Springer (2)
  5. Lippincott Williams & Wilkins (1)
  6. Pioneer Bioscience Publishing Company (1)

More Publishers

Results (19)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Total neoadjuvant FLOT chemotherapy in oesophagogastric adenocarcinoma: An international cohort study
    Meeting Abstract

    Clements, H. A.; Dobrzhanskiy, O.; Yang, J.; Bausys, A.; Ferri, L. E.; Ku, G. Y.; Smyth, E. C.; Underwood, T. J.; Petty, R. D.
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Zanidatamab + chemotherapy for first-line (1L) treatment of HER2+ advanced or metastatic gastro-oesophageal adenocarcinoma (mGEA): New and updated data from a phase II trial
    Meeting Abstract

    Elimova, E.; Ajani, J. A.; Burris, H. A.; Denlinger, C. S.; Iqbal, S.; Kang, Y. K.; Kim, J. H.; Lee, K. W.; Lin, B.; Mehta, R.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Updated safety and efficacy from the phase I study of givastomig, a novel claudin 18.2/4-1BB bispecific antibody, in claudin 18.2 positive advanced gastroesophageal carcinoma (GEC)
    Meeting Abstract

    Klempner, S. J.; Shen, L.; Liu, D.; Dayyani, F.; Kratz, J.; Pan, H.; Liang, X.; Wang, Z.; Kim, S.; Deng, Y.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • The efficacy of plasma exosomal miRNAs as predictive biomarkers for PD-1 blockade plus chemotherapy in gastric cancer
    Journal Article

    Hua, Y.; Luo, S.; Li, Q.; Song, G.; Tian, X.; Wang, P.; Zhu, H.; Lv, S.; Zhang, X.; Yang, Z.; more...
    Translational Cancer Research (2024)

    Fulltext@MSK | Save
  • CLDN18.2 chimeric antigen receptor T cell therapy for patients with advanced gastric and pancreatic adenocarcinoma: Results of ELIMYN18.2 phase 1b clinical trial
    Meeting Abstract

    Botta, G. P.; Kelly, R. J.; Jin, Z.; Ma, H.; Ku, G. Y.; Zhao, D.; Mehta, R.; Carnevale, J. C.; Sierra, G.; Jia, J.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Noninvasive assessment of programmed-death ligand-1 (PD-L1) in esophagogastric (EG) cancer using (18)F-BMS-986229 PET
    Meeting Abstract

    Cytryn, S. L.; Pandit-Taskar, N.; Maron, S. B.; Gu, P.; Ku, G. Y.; Chou, J. F.; Capanu, M.; Feder, L.; Philemond, S.; Lyashchenko, S. K.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Initial safety assessment of the endoscopically injected oncolytic virus OBP-301 in medically inoperable esophageal cancer: NRG-GI007
    Meeting Abstract

    Ku, G. Y.; Moughan, J.; Williams, T. M.; Adusumilli, P. S.; Nishimura, M.; Yock, A.; Mehta, R.; Klempner, S. J.; Miller, E. D.; Hong, T. S.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Phase 1b/II study of durvalumab (D) and tremelimumab (T) plus PET-adjudicated chemoradiation (CRT) in patients (Pts) with esophageal adenocarcinoma
    Meeting Abstract

    Ku, G. Y.; Wu, A. J. C.; Trivedi, N.; Maron, S. B.; Joshi, S. S.; Ilson, D. H.; Janjigian, Y. Y.; Shcherba, M.; Li, J.; Tang, L. H.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Pooled analysis on characteristics of nausea and vomiting in patients receiving trastuzumab deruxtecan (T-DXd) in clinical studies
    Meeting Abstract

    Park, Y. H.; Cortes, J.; Modi, S.; Hurvitz, S. A.; Bianchini, G.; Iwata, H.; Shitara, K.; Siena, S.; Goto, Y.; Ku, G. Y.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Association of ERBB2 extrachromosomal DNA (ecDNA) with first-line HER2-targeted treatment outcomes in advanced esophagogastric adenocarcinoma (EGC)
    Meeting Abstract

    Tsai, C.; Suman, S.; Chu, C.; Chou, J. F.; Krein, P. M.; Capanu, M.; Ilson, D. H.; Ku, G. Y.; Janjigian, Y. Y.; Drilon, A. E.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save